TherapeuticsMD, Inc. — Director's Dealing 2012

Dec 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2012-12-04

Reporting Person: Finizio Robert G (Director, CEO, Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-04-16	Non-Qualified Stock Option	$2.55	A	50000	Acquired	2022-04-16	Common Stock (50000)	Direct
2012-11-30	Non-Qualified Stock Option	$3.00	A	900000	Acquired	2022-11-30	Common Stock (900000)	Direct

Footnotes

F1: Shares vest at the rate of 300,000 shares on 11/8/15. 300,000 shares on 11/8/14, and 300,000 shares on 11/8/15.